全文获取类型
收费全文 | 2985篇 |
免费 | 185篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 120篇 |
儿科学 | 105篇 |
妇产科学 | 136篇 |
基础医学 | 304篇 |
口腔科学 | 132篇 |
临床医学 | 281篇 |
内科学 | 690篇 |
皮肤病学 | 64篇 |
神经病学 | 128篇 |
特种医学 | 149篇 |
外科学 | 724篇 |
综合类 | 38篇 |
一般理论 | 2篇 |
预防医学 | 69篇 |
眼科学 | 77篇 |
药学 | 82篇 |
中国医学 | 6篇 |
肿瘤学 | 91篇 |
出版年
2023年 | 20篇 |
2022年 | 25篇 |
2021年 | 85篇 |
2020年 | 35篇 |
2019年 | 55篇 |
2018年 | 65篇 |
2017年 | 56篇 |
2016年 | 93篇 |
2015年 | 110篇 |
2014年 | 132篇 |
2013年 | 166篇 |
2012年 | 210篇 |
2011年 | 189篇 |
2010年 | 118篇 |
2009年 | 126篇 |
2008年 | 214篇 |
2007年 | 224篇 |
2006年 | 194篇 |
2005年 | 175篇 |
2004年 | 161篇 |
2003年 | 126篇 |
2002年 | 111篇 |
2001年 | 51篇 |
2000年 | 70篇 |
1999年 | 38篇 |
1998年 | 10篇 |
1997年 | 16篇 |
1996年 | 19篇 |
1995年 | 16篇 |
1994年 | 12篇 |
1992年 | 24篇 |
1991年 | 21篇 |
1990年 | 13篇 |
1989年 | 11篇 |
1988年 | 12篇 |
1987年 | 14篇 |
1986年 | 13篇 |
1985年 | 14篇 |
1984年 | 13篇 |
1983年 | 15篇 |
1981年 | 11篇 |
1980年 | 7篇 |
1979年 | 13篇 |
1977年 | 6篇 |
1975年 | 9篇 |
1973年 | 12篇 |
1970年 | 7篇 |
1969年 | 10篇 |
1968年 | 6篇 |
1966年 | 5篇 |
排序方式: 共有3198条查询结果,搜索用时 15 毫秒
71.
A.A. Balik G. Ozturk B. Aydinli F. Alper H. Gumus M.I. Yildirgan 《Acta chirurgica Belgica》2013,113(4):409-412
To review clinical, radiological and histopathological findings of adult intussusception and its management, 18 adult patients who had been treated surgically because of intussusception were reviewed. Of the patients, 5 (27.8%) had idiopathic intussusceptions, while the other 13 (72.2%) had a definable intraluminal pathology. The site of the intussusception was more common in the small bowel (83.3%) than the colon (16.7%). Ultrasonography and computed tomography were successful in demonstrating “target lesion” in 80% and 75% respectively. Patients with idiopathic intussusception were treated with simple reduction, while the others underwent segmental resection because of the possibility of malignant tumour. In contrast to intussusception in childhood, intussusception in adults usually has a definable lead point and resection of the involved bowel, rather than simple reduction, is indicated. 相似文献
72.
73.
74.
75.
76.
77.
78.
Meral Torun Bayram Alper Soylu Halil Ateş Sefa Kızıldağ Salih Kavukçu 《Pediatric nephrology (Berlin, Germany)》2013,28(9):1827-1835
Background
In this study, we aimed to determine the relation of TLR-4 Asp299Gly and Thr399Ile polymorphisms and monocyte/neutrophil TLR-4 expression to febrile urinary tract infection (UTI) and renal scar development in children.Methods
The study was performed in children with a history of febrile UTI. Patients with and without renal scarring were classified as group 1 and group 2, respectively, while the control cases in our previous study were used as the control group (group 3). All three groups were compared for the rate of TLR-4 Asp299Gly and Thr399Ile polymorphisms, and for basal and lipopolysaccharide-stimulated monocyte/neutrophil TLR-4 expression levels.Results
There were 168 patients (86 in group 1, 82 in group 2) and 120 control cases. Monocyte/neutrophil TLR-4 expression levels were similar in groups 1 and 2. However, both groups had lower TLR-4 expression than group 3. The rate of TLR-4 Asp299Gly polymorphism was not different in all groups. TLR-4 Thr399Ile polymorphism was higher in groups 1 and 2 than in group 3 (14.0, 12.2, and 2.0 %, respectively), while group 1 and group 2 were not different. Furthermore, monocyte TLR-4 expression level was lower in those having TLR-4 Thr399Ile polymorphism than in those without this polymorphism.Conclusions
Patients with febrile UTI had more frequent TLR-4 Thr399Ile polymorphism and lower monocyte/neutrophil TLR-4 expression. These findings indicate that children carrying TLR-4 Thr399Ile polymorphism and/or having low level of monocyte/neutrophil TLR-4 expression have a tendency to develop febrile UTI. However, we could not show the association of TLR-4 polymorphisms and of TLR-4 expression level to renal scarring. 相似文献79.
Rubin Zhang Heather LaGuardia Anil Paramesh Katherine Mills Mary Killackey Jennifer McGee Brent Alper Eric Simon Lotuce Lee Hamm Douglas Slakey 《Transplant international》2013,26(6):601-607
Transplanting single pediatric donor kidneys into adult recipients has an increased risk of hyperfiltration injury and graft loss. It is unknown if renin‐angiotensin system (RAS) blockers are beneficial in this setting. We retrospectively analyzed 94 adults who received single kidneys from donors <10 years old during 1996–2009. The recipients were divided into group 1 with RAS blockers (n = 40) and group 2 without RAS blockers (n = 54) in the first year of transplant. There was no significant difference in any donor/recipient demographic between the two groups. Graft function, incidence of delayed graft function, acute rejection, and persistent proteinuria were not statistically different either. Kaplan–Meier estimated death‐censored graft survivals were significantly better in group 1 than in group 2: 95 vs. 81.2%, 82.4 vs. 61.2%, 72.6 vs. 58.5%, and 68.5 vs. 47.2% at 1, 3, 5, and 7 years, respectively (log rank P = 0.043). Multivariable analysis found persistent proteinuria was a risk factor for graft loss (OR 2.70, 95% CI 1.33–5.49, P = 0.006), while RAS blockers reduced the risk of graft loss (OR 0.38, 95% CI 0.18–0.79, P = 0.009). Early RAS blockade therapy in the first year of transplant is associated with superior long‐term graft survival among adults transplanted with single pediatric donor kidneys. 相似文献
80.
Kemal Agbaht Funda Pepedil Alper Kirkpantur Rahmi Yilmaz Cetin Turgan 《Renal failure》2013,35(1):107-110
Kaposi's sarcoma (KS) is an unusual tumor principally affecting the skin of the lower extremities. Although the association between KS and renal transplant has been well documented, there are a few KS cases in the literature associated with membranoproliferative glomerulonephritis or other glomerular diseases. This report presents a patient with membranoproliferative glomerulonephritis (MPGN) who developed KS following treatment with long-term medium dose glucocorticoid and short-term additional immunosuppressives. The KS cases associated with glomerulonephritis are also reviewed. KS is a rare complication in glomerular diseases that may (or may not) be related to immunosuppression. Hence, immunosuppression treatment should be carefully planned in glomerulonephritis treatment and avoided if they are not essentially necessary. 相似文献